Stay updated on Satralizumab in Thyroid Eye Disease Clinical Trial

Sign up to get notified when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Satralizumab in Thyroid Eye Disease Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added new Publications section with a PubMed-listed 2025 study design for satralizumab in thyroid eye disease; no deletions present. This expands the core content with up-to-date research references.
    Difference
    3%
    Check dated 2025-10-12T14:19:18.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Major update to core page content: adds a government funding notice and current operating status details, plus a version bump to v3.2.0; removes the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-05T09:29:06.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Major change: page revision updated to v3.1.0 and several MedlinePlus topics were removed (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs).
    Difference
    0.5%
    Check dated 2025-09-28T03:07:50.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, indicating a minor patch release, and the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-13T16:59:45.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T14:29:39.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, as well as new topics related to drug safety and genetics. Notably, the revision number has been updated to v3.0.0.
    Difference
    5%
    Check dated 2025-08-30T11:16:43.000Z thumbnail image

Stay in the know with updates to Satralizumab in Thyroid Eye Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.